Early research (Phase 1)Study completedNCT06894771
What this trial is testing
MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)
Who this might be right for
Malignant Neoplasm
Merck Sharp & Dohme LLC 5